. . . . . . . . . "1"^^ . . . . . . "20661"^^ . "Poruchy imunitn\u00EDho syst\u00E9mu\nVz\u00E1cn\u00E9: hypersensitivn\u00ED reakce v\u010Detn\u011B angioed\u00E9mu\nEndokrinn\u00ED poruchy\n\u010Cast\u00E9: diabetes mellitus (1)\nPoruchy nervov\u00E9ho syst\u00E9mu\n\u010Cast\u00E9: bolest hlavy, z\u00E1vrat\u011B\nGastrointestin\u00E1ln\u00ED poruchy\n\u010Cast\u00E9: z\u00E1cpa, nevolnost, bolest b\u0159icha\nVz\u00E1cn\u00E9: pankreatitida\nPoruchy k\u016F\u017Ee a podko\u017En\u00ED tk\u00E1n\u011B\nM\u00E9n\u011B \u010Dast\u00E9: sv\u011Bd\u011Bn\u00ED, vyr\u00E1\u017Eka a kop\u0159ivka\nPoruchy svalov\u00E9 a kostern\u00ED soustavy a pojivov\u00E9 tk\u00E1n\u011B\n\u010Cast\u00E9: myalgie\nVz\u00E1cn\u00E9: myopatie (v\u010Detn\u011B myositis) a rhabdomyol\u00FDzy\nCelkov\u00E9 poruchy a reakce v\u00A0m\u00EDst\u011B aplikace\n\u010Cast\u00E9: t\u011Blesn\u00E1 slabost\n(1) Ve studii JUPITER pozorov\u00E1no (celkov\u00E1 frekvence 2,8\u00A0% byla hl\u00E1\u0161ena u rosuvastatinov\u00E9 skupiny a 2,3\u00A0% u placebov\u00E9 skupiny) p\u0159ev\u00E1\u017En\u011B u pacient\u016F s\u00A0hodnotami glyk\u00E9mie nala\u010Dno 5,6 a\u017E 6,9\u00A0mmol/l.\nPodobn\u011B jako u jin\u00FDch inhibitor\u016F HMG-CoA redukt\u00E1zy je v\u00FDskyt ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F \u010Dast\u011Bj\u0161\u00ED p\u0159i zvy\u0161ov\u00E1n\u00ED d\u00E1vky p\u0159\u00EDpravku."@cs . . "19827"^^ . . . .